The costs at a glance
| Published price reference | $183/month Advertised compounded injectable semaglutide starting price |
|---|---|
| Medication | Compounded semaglutide/tirzepatide injections and sublingual preparations; separate branded listings |
| Commitment | Subscriptions renew until canceled; processed prescription orders generally nonrefundable |
| Important context | Compounded tirzepatide starts at $283/month; sublingual semaglutide $203 and tirzepatide $249. Confirm checkout duration, dose, renewal and complete care cost. |
Plans and purchase options
Compounded semaglutide injection
From $183/month; product page includes home kit and expedited shipping
Confirm dose, term and final checkout amount.
Compounded tirzepatide injection
From $283/month
Keep separate from the sublingual product and older navigation-card amount.
Sublingual preparations
Home page starts semaglutide at $203 and tirzepatide at $249 monthly
Do not assume evidence equivalence to an injection.
Delivery format is the reason to examine AlyveRx closely
AlyveRx gives shoppers injectable and injection-free choices, making the format of treatment a central part of the decision. I would resist comparing those choices as if they were interchangeable versions of the same studied product. The route, formulation, prescribed quantity and supporting evidence all matter. Someone who prefers to avoid injections may find the menu interesting, but preference alone cannot establish whether a preparation is suitable or how it performs. My review therefore puts the actual prescription ahead of the platform’s technology branding and treats every price as belonging to one specific product and purchase arrangement.
The injectable starting prices are not the same
The compounded semaglutide product page advertises a starting figure of $183 per month, while compounded tirzepatide starts at $283 per month. Both pages describe a weekly injectable treatment with a vial and home kit, plus free expedited shipping. A vial volume does not by itself establish the number of prescribed doses it contains; concentration and dose determine that. I would ask for a written breakdown showing the exact preparation, usable supply and full amount collected before checkout. Also confirm whether the starting figure changes with dose or purchase duration, because a product card cannot settle the complete treatment budget.
Sublingual pricing belongs in a separate comparison
The home page lists semaglutide sublingual drops from $203 monthly and tirzepatide sublingual drops from $249 monthly. Those figures should not be compared with injectable clinical-trial outcomes as though the route had no importance. I would ask the prescriber what evidence supports the particular sublingual preparation, what benefit is being expected and what uncertainty remains. A convenient delivery format can be a preference, but the decision still needs a clinical rationale. For readers comparing cost, keep the sublingual and injection offers on different lines so the lower number does not silently switch the product being evaluated. For a closer look, read our oral semaglutide evidence guide.
PermeAct claims need product-specific support
AlyveRx devotes substantial space to PermeAct delivery technology and describes research into ingredient uptake. I would separate evidence about a delivery platform from evidence that a finished GLP-1 preparation produces a particular clinical outcome. Ask which studies used the same medicine, formulation, route and population as the proposed treatment. General statements about absorption do not answer all of those questions. This is the part of the site where a careful reader can add the most value to the consultation: request the actual research reference and ask the clinician to explain its relevance rather than relying on technology language alone. For a closer look, read our guide to reading GLP-1 research.
Independent medical care should remain identifiable
The terms describe Alyve as a platform facilitating care from independent licensed healthcare providers through affiliated professional entities. That matters when determining who is responsible for prescribing and clinical follow-up. Before treatment, identify the clinician or practice and the dispensing pharmacy, then establish which channel handles medical questions versus delivery or billing problems. The product pages describe ongoing support, but I would still ask how a dose concern is escalated and whether a live visit is available when necessary. A unified website experience does not mean every organization involved has the same role or responsibility.
Do not combine branded and compounded listings
AlyveRx’s menu also displays branded Ozempic, Mounjaro and Wegovy offers at substantially different starting amounts. Those listings should be discussed separately from the compounded injections and drops. Ask the clinician which exact product is being offered, whether its intended use fits your situation and what the full pharmacy cost would be. For compounded preparations, ask why that preparation is being selected rather than assuming a platform menu settles the question. I would not allow an image or familiar ingredient name to obscure whether the prescription is for an FDA-approved finished product or a compounded medication.
Cancellation has an order-processing cutoff
AlyveRx’s terms describe automatic subscription renewal and generally nonrefundable charges once an order has been processed. They also describe possible prorated treatment-unavailability refunds for an unshipped portion of a prepaid plan. I would clarify those two situations before purchasing: choosing to stop is not necessarily treated the same as a treatment becoming unavailable. Ask for the current support contact and next billing date, and obtain confirmation when canceling. The version reviewed contains a placeholder support-email reference in its cancellation language, making it especially sensible to verify the working route rather than discover that detail close to renewal. For a closer look, read our subscription cancellation guide.
My take: decide on evidence before choosing convenience
AlyveRx can be useful to investigate when delivery preferences are important and the reader wants to compare several preparations. The strongest buying approach is to choose the clinical question first, then assess the format and full cost. I would be cautious about selecting sublingual treatment mainly from broad delivery-technology claims or applying injectable study results to it. Strut Health offers another product-specific comparison, while Found provides a different continuing-care discussion. Neither comparison replaces individual prescribing judgment. My decision would turn on product-specific evidence, a clear clinician relationship and the final renewal terms, rather than the breadth of the catalog. For a closer look, read our Strut Health review.
Before you sign up
- Which studies tested the exact sublingual preparation you are recommending?
- Does the injectable starting amount require a longer purchase or change with dose?
- What working support channel should I use to cancel before another order is processed?
Use the answers to compare the exact offer with another provider. A service review cannot determine whether a medication is appropriate for you; that decision belongs with your clinician.
Compare the complete budget · Save your provider checklist